AR

Abdul Rahim

Active Director Director DIN 09487017
DIN 09487017 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Abdul Rahim

Data last updated:

Abdul Rahim is a Director at Heptakings Impex Private Limited (since 2022). The company operates in Pharma. Heptakings Impex Private Limited reported revenue of ₹4.97 Cr (FY 2024).

DIN 09487017
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 2022
Oldest Company Age 18 yrs
Largest company Heptakings Impex Private Limited · ₹4.97 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Heptakings Impex Private Limited U51909TN2008PTC068657
Director01 Feb 20222008₹4.97 Cr (FY 2024)Active

Board colleagues of Abdul Rahim

Directorship timeline

Open interactive timeline →
Heptakings Impex Private Limited
Premium access

Shareholding and investment profile for Abdul Rahim

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Rahim

Abdul Rahim currently holds 1 directorship: Heptakings Impex Private Limited (Director, since 01 Feb 2022, revenue ₹4.97 Cr (FY 2024)).

Abdul Rahim was first appointed on 01 Feb 2022 as Director at Heptakings Impex Private Limited.

The current boards of Abdul Rahim's companies include Kalil Ahamed Fazal Ahamed (Heptakings Impex Private Limited), Thiyagarajan Raghavan (Heptakings Impex Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available